Sign in

Portal Biotech

@portalbiotech.bsky.social
54 followers 58 following 1 posts

Portal is revolutionising biosensing by bringing precise and universal nanopore-based proteomics and metabolomics solutions to the bench-top.

PostsRepliesMedia
Portal Biotech @portalbiotech.bsky.social · 02/07/2025
Portal Biotech Closes $35M Series A to Deliver First Full-Length Single-Molecule Protein Sequencer. Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore
39
Leadership team at Portal Biotech, from the left to the right: Tim Massingham (VP ML & Bioinformatics), Andrew Heron (Co-Founder & CEO), Giovanni Maglia (Co-Founder & CSO) and Selly Saini (COO). Photography credits: Panji Kaonga
043
Reposted by Portal Biotech
VIB Tech Watch @vibtechwatch.bsky.social · 02/04/2025
“The most important applications of protein sequencing will be the ones we have no idea about today”. Giovanni Maglia founder of Portal Biotech and keynote speaker of #RNGS25, during a chat with our flying reporter Sarah Geurs, Technology Expert at the VIB Tech Watch Core! prez.ly/Zmid
prez.ly
“The most important applications of protein sequencing will be the ones we have no idea about today”
Giovanni Maglia reflects on the future of next-generation proteomics and the challenges of de novo protein sequencing
112